| |
 |
Background and Needs Assessment
Pain associated with diabetic neuropathy is commonly encountered in clinical practice. Currently, the World Health Organization estimates that 130 million people have diabetes, and since the incidence of diabetic neuropathy approaches 50%, the problem is enormous. Diabetic neuropathy encompasses a wide range of abnormalities affecting both the peripheral and autonomic nervous systems. A broad spectrum of therapeutic alternatives to this clinical problem are available. Careful assessment and a rational approach based on the nature and location of pain can lead to success. Accordingly, it is important for pharmacists, endocrinologists, and primary care physicians to be updated on the latest information regarding the prevalence, pathophysiology, and treatment of this complex problem.
This program is accredited for medical and pharmacy continuing education credit.
Program Objectives
Upon completion of this program, the participant should be able to:
- Discuss the prevalence of diabetic neuropathy, and specifically peripheral diabetic neuropathy.
- Identify those patients who have, or are at risk of contracting, diabetic neuropathy.
- Explain the underlying pathophysiology associated with diabetic neuropathy.
- Describe the signs and symptoms of peripheral diabetic neuropathy.
- Discuss the use of nonpharmacologic and pharmacologic treatments in the management of peripheral diabetic neuropathy.
- Establish management guidelines that can be used to identify and manage peripheral diabetic neuropathy.
Continuing Medical Education
Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Dannemiller Memorial Educational Foundation and MatureHealth Communications.  The Dannemiller Memorial Educational Foundation is accredited by the ACCME to provide continuing medical education for physicians.
Designation of Credit: The Dannemiller Memorial Educational Foundation designates this educational activity for up to 1 hour in category 1 credit towards the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.
Continuing Pharmacy Education
Rutgers, the State University of New Jersey, is approved by the American Council on Pharmaceutical Education (ACPE) as a provider of continuing education and complies with the criteria for continuing pharmaceutical education programming. Pharmacists who successfully complete this program will receive 1.0 contact hour (0.10 CEU) of CPE credit.
The Universal Program Number is 038-999-00-052-H01.
The intended audience for this program is pharmacists, endocrinologists, and primary care physicians.
This slide-lecture activity should take approximately 60 minutes to finish and may be completed in either its printed or audio versions. The audio version contains 45 minutes of recorded material. The participant should first select the version, review the CE Info section, to include the objectives, and then complete the version selected. At the conclusion of the symposium, the participant should proceed to the Registration section by use of the navigational icons. Instructions for completing the post-test, the registration and the participant evaluation are listed in the Registration section. The post-test, registration and evaluation should then be completed and submitted for the awarding of CPE or CME credit.
Supported through an unrestricted educational grant from 
Return to ceanytime.com
|
